Access and R&D, Nature, World Health Organization, India, Russia, United States
development

Organisations. Nature, World Health Organization WHO
Period. 4 – 10 May 2020

World leaders pledge $8 billion for research into vaccine and therapies as well as equitable and timely distribution (Coronavirus Global Response Summit)

The absence of the U.S., India and Russia points to possible fractures in global health diplomacy (Washington Post)

Vaccine could be available as early as 9-24 months (Gates Foundation)

A vaccine likely won’t be available until the end of 2021 due to Phase 2 and 3 clinical trials to ensure safety and efficacy, according to the chair of the WHO Global Outbreak Alert and Response Network (CNBC)

Nature: Multiple vaccines are in competition: how will scientists choose the best?

Rapid review for the anti-coronavirus effect of remdesivir (Drug Discoveries & Therapeutics)

Video: How does Gilead’s drug remdesivir work against coronavirus? (STAT)

Gilead to charge up to US$4,500 for experimental COVID-19 treatment remdesivir (Institute for Clinical and Economic Research)

WHO to engage U.S. and Gilead as data on safety and efficacy emerge to ensure wider availability of remdesivir (CNBC)

GAVI Vaccine Alliance proposes an Advanced Market Commitment program for COVID-19 vaccine (GAVI)

Internet of Things has been deployed in innovative ways to provide information and monitoring during the COVID-19 epidemic, including automated and transparent treatment (Journal of Diabetes & Metabolic Syndrome)

Emerging technologies to combat COVID-19 pandemic (J of Clinical and Experimental Hepatology)

Going Viral: how to boost the spread of coronavirus science on social media (Nature)

COVID-19 has reinforced the importance of preprints as a means for rapid research dissemination (Nature Biotechnology)

Tool: Google releases an AI-powered COVID-19 Research Explorer to assist researchers with complex queries

 

UK researchers create antibody test claiming 100% sensitivity, 99.8% specificity and results in 35 minutes (UK Standard)

U.S. Food and Drug Administration tighten standards for antibody testing following false specificity and sensitivity claims (WSJ)

Ethical and practical challenges of COVID-19 human vaccine trials (STAT)

Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure (Journal of Infections Diseases)

WHO to issue ethical guidelines this month to inform human challenge trials amidst reports of deliberate infection of healthy human volunteers to test vaccine candidates (SCMP)

Frontier technologies for COVID-19 need better governance (WEF)

Unproven herbal remedy, ‘Madagascar Tonic’, touted by some African governments despite warnings from health officials (Globe & Mail; The Economist)

 

This development is part of the digest;